Aeris Capital

GenomeDx discovers, develops, and commercializes genomic-based laboratory tests for the personalized medicine revolution in cancer care. In partnership with physicians and scientists from leading academic medicine institutions, our mission is to bring cost-effective and high-resolution genomics for routine clinical use in cancer medicine.

Jiff, Inc. is a technology company that specializes in providing a HIPAA-compliant platform for the healthcare industry, enabling the creation of personalized and private communities of care. Founded in 2010 and headquartered in Mountain View, California, Jiff focuses on enhancing communication between healthcare professionals and patients through innovative tools. One of its notable products is JiffPad, an educational platform for iPads that transforms doctor-patient conversations and images into videos, facilitating easier sharing and understanding within the privacy of patients' homes. The company also offers solutions that engage employees by linking company benefits and incentives to healthy behaviors, leveraging familiar wearables and applications. Jiff has formed strategic alliances with firms such as Towers Watson & Co. and Mercer, furthering its mission to improve healthcare delivery and employee engagement. As of April 2017, Jiff operates as a subsidiary of Castlight Health, Inc.

Solstice Biologics LLC is a biotechnology company focused on the development of small cell-permeable RNAi pro-drugs designed for the effective targeting and delivery of nucleic acid therapeutics. Founded in 2012 and located in San Diego, California, the company specializes in creating innovative solutions that enable these therapeutics to penetrate various cell types. By utilizing a small double-stranded cellular RNA to selectively degrade specific mRNAs, Solstice Biologics aims to advance the field of RNA interference (RNAi) and enhance the therapeutic potential of nucleic acid-based treatments.

Affimed NV is a clinical-stage biopharmaceutical company focused on developing innovative cancer immunotherapies. With nearly two decades of expertise in innate immunity, Affimed seeks to leverage the innate immune system to enhance cancer treatment outcomes. The company specializes in discovering and advancing targeted therapies through its unique approach of using innate cell engagers, which aim to address the limitations of existing immuno-oncology therapies. In addition to its core research and development efforts, Affimed also generates revenue by providing research and development services to third parties, utilizing both its own and externally licensed intellectual property.

Jiff, Inc. is a technology company that specializes in providing a HIPAA-compliant platform for the healthcare industry, enabling the creation of personalized and private communities of care. Founded in 2010 and headquartered in Mountain View, California, Jiff focuses on enhancing communication between healthcare professionals and patients through innovative tools. One of its notable products is JiffPad, an educational platform for iPads that transforms doctor-patient conversations and images into videos, facilitating easier sharing and understanding within the privacy of patients' homes. The company also offers solutions that engage employees by linking company benefits and incentives to healthy behaviors, leveraging familiar wearables and applications. Jiff has formed strategic alliances with firms such as Towers Watson & Co. and Mercer, furthering its mission to improve healthcare delivery and employee engagement. As of April 2017, Jiff operates as a subsidiary of Castlight Health, Inc.

Curetis AG is a Germany-based company that specializes in developing molecular diagnostics solutions for infectious diseases. Founded in 2015 and now operating as a subsidiary of OpGen, Inc., Curetis focuses on the detection of pathogens and antibiotic resistance markers. The company offers a rapid diagnostic platform that enables multiparameter testing of various analytes in a single run, providing comprehensive panels for detecting a wide range of pathogens and resistance genes. This innovative approach aims to improve patient outcomes by delivering early, actionable information to healthcare providers, particularly in the context of severe bacterial infections. Curetis's technology not only addresses current healthcare challenges but also presents opportunities for future expansions into other clinical applications beyond infectious diseases.

Butterfly Network, Inc. is a medical imaging company based in Guilford, Connecticut, that specializes in handheld ultrasound technology. Founded in 2011, the company has developed the world's first handheld, single-probe whole-body ultrasound system, known as Butterfly iQ, powered by its proprietary Ultrasound-on-Chip technology. This innovative device provides diagnostic imaging for various medical conditions affecting the cardiac, abdominal, urological, fetal, gynecological, and musculoskeletal systems. Butterfly Network aims to democratize access to medical imaging, particularly for the 4.7 billion people globally who lack access to ultrasound services. By integrating cloud-connected software with its ultrasound hardware, Butterfly enhances the clinical workflow, facilitating earlier detection and remote management of health conditions.

Jiff, Inc. is a technology company that specializes in providing a HIPAA-compliant platform for the healthcare industry, enabling the creation of personalized and private communities of care. Founded in 2010 and headquartered in Mountain View, California, Jiff focuses on enhancing communication between healthcare professionals and patients through innovative tools. One of its notable products is JiffPad, an educational platform for iPads that transforms doctor-patient conversations and images into videos, facilitating easier sharing and understanding within the privacy of patients' homes. The company also offers solutions that engage employees by linking company benefits and incentives to healthy behaviors, leveraging familiar wearables and applications. Jiff has formed strategic alliances with firms such as Towers Watson & Co. and Mercer, furthering its mission to improve healthcare delivery and employee engagement. As of April 2017, Jiff operates as a subsidiary of Castlight Health, Inc.

Affimed NV is a clinical-stage biopharmaceutical company focused on developing innovative cancer immunotherapies. With nearly two decades of expertise in innate immunity, Affimed seeks to leverage the innate immune system to enhance cancer treatment outcomes. The company specializes in discovering and advancing targeted therapies through its unique approach of using innate cell engagers, which aim to address the limitations of existing immuno-oncology therapies. In addition to its core research and development efforts, Affimed also generates revenue by providing research and development services to third parties, utilizing both its own and externally licensed intellectual property.

Smaato Inc. is a global advertising technology company that specializes in real-time advertising solutions for mobile publishers, application developers, and advertisers. Founded in 2005 and headquartered in San Francisco, with additional offices in Hamburg and Singapore, Smaato operates the SPX platform, an enterprise-level ad server that simplifies mobile monetization for its clients. This platform integrates various demand and supply sources, allowing publishers to manage their inventory and utilize first-party data effectively. By connecting quality publishers with premium marketers, Smaato enables clients to enhance their revenue potential and engage audiences across multiple devices.

Sonetik AG is a Swiss company based in Bern that specializes in the development of hearing aids for individuals with hearing impairments. The company offers a range of digital hearing aids under the Sonetik GOhear brand, which includes models designed for various types of hearing loss, such as slightly sloping, steeply sloping, high frequency, and flat losses. Sonetik's approach utilizes preset configurations tailored to the most common patterns of hearing loss, allowing their specialists to match the appropriate hearing aid to the user's specific needs based on hearing test results. This method enables users to achieve similar benefits to those of custom-fitted hearing aids, but at a significantly lower cost, making hearing assistance more accessible. Sonetik AG operates as a subsidiary of Harvard International plc.

Invincea, Inc. is a cybersecurity company based in Fairfax, Virginia, specializing in advanced endpoint security software solutions. Founded in 2006 and originally known as Secure Command, LLC, Invincea rebranded in 2010 and has since positioned itself as a leader in endpoint threat protection, serving over 25,000 customers and 3 million active users across various sectors, including education, finance, healthcare, and utilities. The company's flagship product, X by Invincea, leverages machine learning and behavioral monitoring to detect and neutralize sophisticated cyber threats, such as spear phishing and drive-by downloads, without compromising user productivity. Invincea's innovative technology, which originated from DARPA-funded research, has garnered multiple awards for its effectiveness in countering advanced attacks that evade traditional security measures. Additionally, Invincea collaborates with Dell to provide a customized version of its endpoint security solution for commercial PCs and tablets, further extending its market presence and impact. As of 2017, Invincea operates as a subsidiary of Sophos Group plc.

GenomeDx discovers, develops, and commercializes genomic-based laboratory tests for the personalized medicine revolution in cancer care. In partnership with physicians and scientists from leading academic medicine institutions, our mission is to bring cost-effective and high-resolution genomics for routine clinical use in cancer medicine.

Atlantium Technologies Ltd., founded in 2003, specializes in advanced water treatment solutions utilizing ultraviolet (UV) disinfection technology. The company’s innovative approach integrates fiber-optic and hydraulic principles, allowing for uniform UV dose distribution, which enhances microbial inactivation and sets new standards in water safety without relying on chemicals. Atlantium’s systems have been successfully deployed globally, serving a diverse clientele that includes Fortune 500 companies. The company emphasizes sustainable and measurable treatment options, and it has established customer service centers to provide ongoing support to its users. As a fast-growing private entity, Atlantium is dedicated to delivering effective water purification methods that prioritize safety and sustainability.

Solstice Biologics LLC is a biotechnology company focused on the development of small cell-permeable RNAi pro-drugs designed for the effective targeting and delivery of nucleic acid therapeutics. Founded in 2012 and located in San Diego, California, the company specializes in creating innovative solutions that enable these therapeutics to penetrate various cell types. By utilizing a small double-stranded cellular RNA to selectively degrade specific mRNAs, Solstice Biologics aims to advance the field of RNA interference (RNAi) and enhance the therapeutic potential of nucleic acid-based treatments.

Crescendo Bioscience, Inc. is a molecular diagnostics company specializing in rheumatology, founded in 2002 and located in South San Francisco, California. The company develops quantitative and objective diagnostic tools aimed at assisting rheumatologists in the management of autoimmune and inflammatory diseases. Its primary product, Vectra DA, is a standardized multi-biomarker blood test designed to assess disease activity in rheumatoid arthritis. This test enables rheumatologists to effectively monitor and manage patients by providing critical disease information and insights. Through its innovative diagnostic and prognostic capabilities, Crescendo Bioscience enhances the decision-making process for therapy selection and patient management.

Solstice Biologics LLC is a biotechnology company focused on the development of small cell-permeable RNAi pro-drugs designed for the effective targeting and delivery of nucleic acid therapeutics. Founded in 2012 and located in San Diego, California, the company specializes in creating innovative solutions that enable these therapeutics to penetrate various cell types. By utilizing a small double-stranded cellular RNA to selectively degrade specific mRNAs, Solstice Biologics aims to advance the field of RNA interference (RNAi) and enhance the therapeutic potential of nucleic acid-based treatments.

Affimed NV is a clinical-stage biopharmaceutical company focused on developing innovative cancer immunotherapies. With nearly two decades of expertise in innate immunity, Affimed seeks to leverage the innate immune system to enhance cancer treatment outcomes. The company specializes in discovering and advancing targeted therapies through its unique approach of using innate cell engagers, which aim to address the limitations of existing immuno-oncology therapies. In addition to its core research and development efforts, Affimed also generates revenue by providing research and development services to third parties, utilizing both its own and externally licensed intellectual property.

Nanosolar, Inc. is a manufacturer of solar electricity cells and panels, focusing on cost-efficient solar energy solutions. Founded in 2001 and headquartered in San Jose, California, with additional manufacturing facilities in Berlin, Germany, the company produces products such as the Utility Panel, designed for utility-scale power plants, and SolarPly, a lightweight solar-electric cell foil that can be customized to various sizes. Nanosolar employs a proprietary printing technique for CIGS (Copper, Indium, Gallium, Selenium) solar cells, utilizing nanoparticle inks and an annealing process. This innovative approach reduces reliance on expensive high vacuum deposition equipment, allowing the company to leverage industrial printing and roll-to-roll manufacturing technologies to produce solar-electric foil efficiently and at high speeds.

Jiff, Inc. is a technology company that specializes in providing a HIPAA-compliant platform for the healthcare industry, enabling the creation of personalized and private communities of care. Founded in 2010 and headquartered in Mountain View, California, Jiff focuses on enhancing communication between healthcare professionals and patients through innovative tools. One of its notable products is JiffPad, an educational platform for iPads that transforms doctor-patient conversations and images into videos, facilitating easier sharing and understanding within the privacy of patients' homes. The company also offers solutions that engage employees by linking company benefits and incentives to healthy behaviors, leveraging familiar wearables and applications. Jiff has formed strategic alliances with firms such as Towers Watson & Co. and Mercer, furthering its mission to improve healthcare delivery and employee engagement. As of April 2017, Jiff operates as a subsidiary of Castlight Health, Inc.

GenomeDx discovers, develops, and commercializes genomic-based laboratory tests for the personalized medicine revolution in cancer care. In partnership with physicians and scientists from leading academic medicine institutions, our mission is to bring cost-effective and high-resolution genomics for routine clinical use in cancer medicine.

Crescendo Bioscience, Inc. is a molecular diagnostics company specializing in rheumatology, founded in 2002 and located in South San Francisco, California. The company develops quantitative and objective diagnostic tools aimed at assisting rheumatologists in the management of autoimmune and inflammatory diseases. Its primary product, Vectra DA, is a standardized multi-biomarker blood test designed to assess disease activity in rheumatoid arthritis. This test enables rheumatologists to effectively monitor and manage patients by providing critical disease information and insights. Through its innovative diagnostic and prognostic capabilities, Crescendo Bioscience enhances the decision-making process for therapy selection and patient management.

SynapSense provides complete wireless instrumentation solutions that offer energy efficiency and carbon footprint reduction for the world's leading data centers and enterprises.

Smaato Inc. is a global advertising technology company that specializes in real-time advertising solutions for mobile publishers, application developers, and advertisers. Founded in 2005 and headquartered in San Francisco, with additional offices in Hamburg and Singapore, Smaato operates the SPX platform, an enterprise-level ad server that simplifies mobile monetization for its clients. This platform integrates various demand and supply sources, allowing publishers to manage their inventory and utilize first-party data effectively. By connecting quality publishers with premium marketers, Smaato enables clients to enhance their revenue potential and engage audiences across multiple devices.

Curetis AG is a Germany-based company that specializes in developing molecular diagnostics solutions for infectious diseases. Founded in 2015 and now operating as a subsidiary of OpGen, Inc., Curetis focuses on the detection of pathogens and antibiotic resistance markers. The company offers a rapid diagnostic platform that enables multiparameter testing of various analytes in a single run, providing comprehensive panels for detecting a wide range of pathogens and resistance genes. This innovative approach aims to improve patient outcomes by delivering early, actionable information to healthcare providers, particularly in the context of severe bacterial infections. Curetis's technology not only addresses current healthcare challenges but also presents opportunities for future expansions into other clinical applications beyond infectious diseases.

Smaato Inc. is a global advertising technology company that specializes in real-time advertising solutions for mobile publishers, application developers, and advertisers. Founded in 2005 and headquartered in San Francisco, with additional offices in Hamburg and Singapore, Smaato operates the SPX platform, an enterprise-level ad server that simplifies mobile monetization for its clients. This platform integrates various demand and supply sources, allowing publishers to manage their inventory and utilize first-party data effectively. By connecting quality publishers with premium marketers, Smaato enables clients to enhance their revenue potential and engage audiences across multiple devices.

Coda Automotive builds eco-friendly transportation -- chiefly electric cars -- to create a livable future for generations to come. Headquartered in Southern California, CODA Automotive teamed with American partners to develop an American designed and manufactured electric drivetrain as well as battery system electronics to serve as the foundation for the CODA car. They also partnered with the most highly proficient and advanced companies from around the world, from China to Europe, to build a safe and affordable all-electric car. All the while, CODA Automotive maintained control of brand, design, and critical intellectual property.

Livescribe, Inc. is a technology company based in Oakland, California, specializing in the design and manufacture of smartpens that facilitate the capture, search, and sharing of handwritten notes on digital devices. Founded in 2007, the company offers a range of smartpens, including the Sky Wi-Fi smartpen, which transfers recorded notes and audio to cloud accounts for access on various devices, and the Echo smartpen, which connects to computers via USB for interactive note transfer. Additionally, the Livescribe 3 smartpen utilizes Bluetooth technology to send written data to smartphones and tablets. Livescribe's products cater to a diverse audience, including students, educators, and professionals, aiding them in capturing and sharing their written and auditory experiences. The company also provides associated products such as dot paper, ink, and accessories through online channels. Livescribe operates as a subsidiary of Anoto Group AB.

Coda Automotive builds eco-friendly transportation -- chiefly electric cars -- to create a livable future for generations to come. Headquartered in Southern California, CODA Automotive teamed with American partners to develop an American designed and manufactured electric drivetrain as well as battery system electronics to serve as the foundation for the CODA car. They also partnered with the most highly proficient and advanced companies from around the world, from China to Europe, to build a safe and affordable all-electric car. All the while, CODA Automotive maintained control of brand, design, and critical intellectual property.

Affimed NV is a clinical-stage biopharmaceutical company focused on developing innovative cancer immunotherapies. With nearly two decades of expertise in innate immunity, Affimed seeks to leverage the innate immune system to enhance cancer treatment outcomes. The company specializes in discovering and advancing targeted therapies through its unique approach of using innate cell engagers, which aim to address the limitations of existing immuno-oncology therapies. In addition to its core research and development efforts, Affimed also generates revenue by providing research and development services to third parties, utilizing both its own and externally licensed intellectual property.

Mode Media, a top 10 U.S. media property with 136 million unique users a month, was founded in Silicon Valley in 2004 with a simple, yet powerful idea—to help people discover relevant content by combining the power of human curation of premium content with technology that distributes the right content to the right people at the right time. Today, Mode Media is building the largest independent premium video and content platform for creators powered by distribution and streaming technology that delivers targeted native videos, content and branded entertainment at scale in real-time. Mode.com is an owned & operated social networking platform where creators can upload videos and build content stories. Content on Mode is curated by professional editors and distributed in user feeds—personalized by the Mode content algorithm technology. Since launch six months ago, Mode has grown from zero to 31 million unique monthly users, and crossed over 1 billion streamed video views.

Curetis AG is a Germany-based company that specializes in developing molecular diagnostics solutions for infectious diseases. Founded in 2015 and now operating as a subsidiary of OpGen, Inc., Curetis focuses on the detection of pathogens and antibiotic resistance markers. The company offers a rapid diagnostic platform that enables multiparameter testing of various analytes in a single run, providing comprehensive panels for detecting a wide range of pathogens and resistance genes. This innovative approach aims to improve patient outcomes by delivering early, actionable information to healthcare providers, particularly in the context of severe bacterial infections. Curetis's technology not only addresses current healthcare challenges but also presents opportunities for future expansions into other clinical applications beyond infectious diseases.

Smaato Inc. is a global advertising technology company that specializes in real-time advertising solutions for mobile publishers, application developers, and advertisers. Founded in 2005 and headquartered in San Francisco, with additional offices in Hamburg and Singapore, Smaato operates the SPX platform, an enterprise-level ad server that simplifies mobile monetization for its clients. This platform integrates various demand and supply sources, allowing publishers to manage their inventory and utilize first-party data effectively. By connecting quality publishers with premium marketers, Smaato enables clients to enhance their revenue potential and engage audiences across multiple devices.

Tethys BioScience, Inc. engages in the discovery, development, and commercialization of biological markers. Its products are used to diagnosis the metabolic diseases, such as diabetes. The company offers PreDx Diabetes Risk Test, a diagnostic test that analyzes a set of multiple proteins and other blood borne biomarkers implicated in the development of diabetes. Tethys BioScience, Inc. was founded in 2002 and is based in Emeryville, California.

Adamas Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the discovery, development, and commercialization of medicines for chronic neurologic disorders. Headquartered in Emeryville, California, the company offers GOCOVRI, an extended-release capsule designed to treat dyskinesia in patients with Parkinson's disease who are undergoing levodopa-based therapy. Adamas is also advancing the development of ADS-5102, currently in Phase III clinical studies targeting walking impairment in patients with multiple sclerosis, and ADS-4101, which has completed Phase I studies for partial onset seizures in epilepsy. Additionally, Adamas provides Namzaric, a combination therapy for moderate to severe Alzheimer's dementia. Founded in 2000, the company operates primarily in the United States, with a focus on addressing healthcare challenges associated with central nervous system disorders.

ConforMIS is a medical technology company based in the United States that specializes in joint replacement implants and instruments. Utilizing its proprietary iFit® Image-to-Implant® technology platform, ConforMIS develops and manufactures personalized implants that are uniquely sized and shaped to match each patient's anatomy. The company's offerings include a wide range of sterile knee and hip implants, such as partial and total knee replacements, along with single-use surgical instruments. ConforMIS's iFit technology encompasses design, printing, and just-in-time delivery, allowing for customized solutions that enhance patient outcomes. The company primarily generates revenue through sales to hospitals and ambulatory surgical centers, positioning itself within the knee replacement market.

ConforMIS is a medical technology company based in the United States that specializes in joint replacement implants and instruments. Utilizing its proprietary iFit® Image-to-Implant® technology platform, ConforMIS develops and manufactures personalized implants that are uniquely sized and shaped to match each patient's anatomy. The company's offerings include a wide range of sterile knee and hip implants, such as partial and total knee replacements, along with single-use surgical instruments. ConforMIS's iFit technology encompasses design, printing, and just-in-time delivery, allowing for customized solutions that enhance patient outcomes. The company primarily generates revenue through sales to hospitals and ambulatory surgical centers, positioning itself within the knee replacement market.

mobileo was founded with the aim of "distributing relevant content on the mobile Internet". The company was based in Hamburg (Germany) , and founded by Freddie Geier, former head of Apple Germany. As a main line for its development, mobileo wanted to enable a channel of distribution for content providers on the mobile internet, focusing around a core element, the location. In particular mobileo was very keen on providing a solution for the publishing industry in regards to the challenge of mobility, as well as on allowing the end user to contribute through the sharing of her/his favorite locations. A complete ecosystem was developed consisting of import (and normalization) components, a storage system, a server component, and mobile clients. All along this processing chain, usage was made of an internally developed technology, enabling the expression of relevance (where, when, what) for the content aggregation. This ecosystem was the foundation for both products for external customers, as well as for an own consumer product, GRYD. On the day of the launch of their consumer platform, GRYD, mobileo had to file bankruptcy due to the reason that the investor didn't fulfill is obligations.

Smaato Inc. is a global advertising technology company that specializes in real-time advertising solutions for mobile publishers, application developers, and advertisers. Founded in 2005 and headquartered in San Francisco, with additional offices in Hamburg and Singapore, Smaato operates the SPX platform, an enterprise-level ad server that simplifies mobile monetization for its clients. This platform integrates various demand and supply sources, allowing publishers to manage their inventory and utilize first-party data effectively. By connecting quality publishers with premium marketers, Smaato enables clients to enhance their revenue potential and engage audiences across multiple devices.